These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21406436)

  • 1. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
    Cirioni O; Ghiselli R; Silvestri C; Minardi D; Gabrielli E; Orlando F; Rimini M; Brescini L; Muzzonigro G; Guerrieri M; Giacometti A
    J Antimicrob Chemother; 2011 Jun; 66(6):1318-23. PubMed ID: 21406436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antimicrobial peptide tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model.
    Minardi D; Ghiselli R; Cirioni O; Giacometti A; Kamysz W; Orlando F; Silvestri C; Parri G; Kamysz E; Scalise G; Saba V; Giovanni M
    Peptides; 2007 Dec; 28(12):2293-8. PubMed ID: 18022289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
    Wang X; Cai Y; Xing H; Wu W; Wang G; Li L; Chen J
    BMC Microbiol; 2016 Jun; 16(1):124. PubMed ID: 27341798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tigecycline and rifampin alone and in combination against Enterococcus faecalis biofilm infection in a rat model of ureteral stent.
    Minardi D; Cirioni O; Ghiselli R; Silvestri C; Mocchegiani F; Gabrielli E; d'Anzeo G; Conti A; Orlando F; Rimini M; Brescini L; Guerrieri M; Giacometti A; Muzzonigro G
    J Surg Res; 2012 Jul; 176(1):1-6. PubMed ID: 21704328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
    Elkhatib W; Noreddin A
    Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
    Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model.
    Cai Y; Fan Y; Wang R; An MM; Liang BB
    J Antimicrob Chemother; 2009 Sep; 64(3):563-6. PubMed ID: 19561148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
    Meers P; Neville M; Malinin V; Scotto AW; Sardaryan G; Kurumunda R; Mackinson C; James G; Fisher S; Perkins WR
    J Antimicrob Chemother; 2008 Apr; 61(4):859-68. PubMed ID: 18305202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycin.
    Garey KW; Vo QP; Lewis RE; Saengcharoen W; LaRocco MT; Tam VH
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):81-6. PubMed ID: 18990530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.
    Orlando F; Ghiselli R; Cirioni O; Minardi D; Tomasinsig L; Mocchegiani F; Silvestri C; Skerlavaj B; Riva A; Muzzonigro G; Saba V; Scalise G; Zanetti M; Giacometti A
    Peptides; 2008 Jul; 29(7):1118-23. PubMed ID: 18430491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa.
    Kondoh K; Hashiba M; Baba S
    Acta Otolaryngol Suppl; 1996; 525():56-60. PubMed ID: 8908271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis.
    Kandemir O; Oztuna V; Milcan A; Bayramoğlu A; Celik HH; Bayarslan C; Kaya A
    Clin Orthop Relat Res; 2005 Jan; (430):171-5. PubMed ID: 15662320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction between biofilm formed by Pseudomonas aeruginosa and antibacterial agents].
    Feng X; Zhao G; Cui L; Guan X; Wang H
    Wei Sheng Wu Xue Bao; 2000 Apr; 40(2):210-3. PubMed ID: 12548947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
    Jennings JA; Carpenter DP; Troxel KS; Beenken KE; Smeltzer MS; Courtney HS; Haggard WO
    Clin Orthop Relat Res; 2015 Jul; 473(7):2270-82. PubMed ID: 25604874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of three-dimensional lung epithelial cells and interspecies interactions on antibiotic efficacy against Mycobacterium abscessus and Pseudomonas aeruginosa.
    Rodríguez-Sevilla G; Rigauts C; Vandeplassche E; Ostyn L; Mahíllo-Fernández I; Esteban J; Peremarch CP; Coenye T; Crabbé A
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29648588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro].
    Xu Z; Liu F; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):342-4. PubMed ID: 11802985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.
    Cirioni O; Ghiselli R; Minardi D; Orlando F; Mocchegiani F; Silvestri C; Muzzonigro G; Saba V; Scalise G; Balaban N; Giacometti A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4518-20. PubMed ID: 17875996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model.
    Christensen LD; van Gennip M; Jakobsen TH; Alhede M; Hougen HP; Høiby N; Bjarnsholt T; Givskov M
    J Antimicrob Chemother; 2012 May; 67(5):1198-206. PubMed ID: 22302561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.